Clinical Trial Update: ACTiF- Assessment of Closed Tibial Fractures [Phase 2]

View source ↗

Summary

Pfizer's Phase 2 ACTiF trial evaluating treatment for closed tibial fractures has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tibial Fracture

Snippet

Sponsor: Pfizer | Conditions: Tibial Fractures | Phase 2 | Status: COMPLETED